台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

(MP02-01) Trend of life expectancy as references for radical prostatectomy of prostate cancer in Taiwan—2023 update

2024-01-10 • 觀看: 996 • 回應: 0 • doc
(MP01-09) The early learning curve of extraperitoneal laparoscopic radical prostatectomy and peri-operative outcome analysis

2024-01-10 • 觀看: 896 • 回應: 0 • doc
(MP01-08) The neural mechanisms of renal R2 chemoreceptor in LPS-induced SA-AKI

2024-01-10 • 觀看: 931 • 回應: 0 • doc
(MP01-07) A retrospective risk factor analysis of acute kidney injury in patients with ureteral stones

2024-01-10 • 觀看: 938 • 回應: 0 • doc
(MP01-06) Synchronous and metachronous bilateral testicular seminoma: Report of two cases and literature review

2024-01-10 • 觀看: 937 • 回應: 0 • doc
(MP01-05) Oncological outcomes of primary bladder adenocarcinoma and urachal adenocarcinoma in a single center

2024-01-10 • 觀看: 1030 • 回應: 0 • doc
(MP01-04) Comparison of sarcomatoid urothelial carcinoma in urinary bladder and upper urinary tract: A single-center experience and literature review

2024-01-10 • 觀看: 909 • 回應: 0 • doc
(MP01-03) The association of matrix metalloproteinase 9 genotypes on renal cell carcinoma risks in mid-Taiwan

2024-01-10 • 觀看: 966 • 回應: 0 • doc
(MP01-02) Testosterone breakthrough rates during androgen deprivation therapy for castration sensitive prostate cancer

2024-01-10 • 觀看: 1003 • 回應: 0 • doc
(MP01-01) MRI-US fusion prostate biopsy in diagnosis of prostate cancer: A preliminary experience of 3 years

2024-01-10 • 觀看: 1092 • 回應: 0 • doc
PD03-6: Age-related differences in risk factors and clinical presentations of fournier's gangrene

2024-01-10 • 觀看: 900 • 回應: 0 • doc
PD03-5: The impact of COVID-19 on the management of fournier's gangrene: What have we learned?

2024-01-10 • 觀看: 917 • 回應: 0 • doc

Prev
248
249
250
251
252
253
254
255
256
257
Next
/ 1134